Skip to content
Biotechnology, Business Company News

Jane Morgan and Brian Leedman Appointed to the Board of Directors of BlinkLab – Early and Accurate Detection of Autism using an AI-driven Smartphone Platform.

BlinkLab 2 mins read

BlinkLab, the groundbreaking early detection diagnostic tool for Autism and other neurological disorders, is pleased to announce the appointments of Jane Morgan as a Non-Executive Director and Brian Leedman as Chairman of the Board. These significant additions to the board come as BlinkLab prepares for listing on the Australian Securities Exchange (ASX), with Westar Capital as the lead manager for the IPO.

 

Jane Morgan, Founder, and Director of Investor and Media Relations firm JMM, is a seasoned professional with a wealth of experience in strategic communications and investor relations. Her extensive background makes her an invaluable asset to BlinkLab's leadership team.

 

Brian Leedman, a highly respected figure in the financial and business community, will serve as Chairman of the Board. With a remarkable career spanning various industries, including finance, technology, and healthcare, Mr. Leedman brings a depth of knowledge and a strategic perspective that will greatly benefit BlinkLab. He is the co-founder and Executive Director of highly successful digital healthcare company, ResApp Health (ASX:RAP) that was acquired by Pfizer in September 2022 for its regulatory approved cough-based respiratory disease screening test using only a smartphone. 

 

BlinkLab, a Princeton University technology founded two years ago by Dr. Henk-Jan Boele (MD, PhD) and his scientific team, is at the forefront of early diagnosis of autism and ADHD. The company has a fully developed a neurometric testing platform that leverages computer vision, machine learning, and artificial intelligence. The platform utilizes conventional smartphones and tablets as neurological data collection tools.

 

Currently, the diagnosis of neurological disorders can take up to a year and a half to complete, requiring the approval of several clinical specialists. This process typically occurs when the patient is five years old, which is generally considered as too late for effective therapeutic treatment. BlinkLab, however, is revolutionizing this paradigm by reducing the diagnostic evaluation process to one or two 15-minute smartphone based neurometric tests that potentially can bring down the diagnostic age to as low as 18 months of age, yet with an accuracy above currently FDA approved products. This breakthrough promises to make a significant impact by allowing therapeutic treatment at an age when neural pathways are still forming in the brain, facilitating effective rewiring of these pathways and significantly bringing down medical expenses for families and healthcare systems.

 

The ASX listing will raise an estimated A$6-8 million, providing BlinkLab with the necessary resources to pursue its FDA registrational study over the next 24 months. This milestone marks a pivotal moment in the company's journey towards improving the lives of individuals affected by neurological disorders including autism.

 

BlinkLab's association with Jane Morgan and Brian Leedman underscores its commitment to excellence and innovation in the field of early diagnosis and intervention for neurological disorders. With their wealth of experience and strategic vision, Ms. Morgan and Mr. Leedman will play vital roles in guiding BlinkLab's mission to change the status quo in neurological disorder diagnosis and treatment.


Key Facts:

Scientific Report published in Nature, 18 December 2023: 

Accessible and reliable neurometric testing in humans using a smartphone platform


https://www.nature.com/articles/s41598-023-49568-2


About us:

BlinkLab is a Princeton University technology founded by Dr. Henk-Jan Boele and Dr. Anton Uvarov and their scientific team, specializing in early detection and diagnosis of neurological disorders using innovative technology. The company's mission is to reduce the age of diagnosis and enable more effective therapeutic treatment for individuals with neurological disorders.

Website: www.blinklab.org


Contact details:

Jane Morgan 
jane@blinklab.org

Media

More from this category

  • Business Company News, Food Beverages
  • 19/07/2024
  • 12:50
Brisbane Convention & Exhibition Centre (BCEC)

Seasoned by Queensland – this is how to feed our visitors!

Local Produce the Standout at Brisbane Convention & Exhibition Centre MENU LAUNCH Brisbane Convention & Exhibition Centre (BCEC) has launched its 2024 Menu, Seasoned…

  • Contains:
  • Business Company News, Indigenous
  • 18/07/2024
  • 16:07
Parliament of Australia

Melbourne hearing for inquiry into improving the economic self-determination for First Nations Australians

The Joint Standing Committee on Aboriginal and Torres Strait Islander Affairs will hold a public hearing in Melbourne on 19 July for the inquiry into improving the economic prosperity for First Nations Australians. The Committee is looking forward to hearing firsthand from Victoria’s Aboriginal and Torres Strait Islander organisations at the forefront of business enterprise, about the barriers to and opportunities for economic development for First Nations people. The Committee will discuss the latest research from the Dilin Duwa – Centre for Indigenous Business Leadership and the University of Melbourne about the enormous contribution of Indigenous businesses to the Australian…

  • Business Company News, Oil Mining Resources
  • 18/07/2024
  • 11:04
Jane Morgan Management

Resouro Strategic Metals Inc. (ASX:RAU) Announces Maiden JORC Resource for the Tiros Project

Sydney, Australia, 18 July 2024 | Resouro Strategic Metals Inc. (ASX:RAU; TSX-V:RSM; FSE:BU9; OTC:RSGOGF) is pleased to announce the publication of its maiden JORC-compliant Mineral Resource Estimate (“MRE”) for the Tiros Titanium and Rare Earth Elements Project in Brazil (“Tiros Project” or “Tiros” or “Project”). This marks a significant milestone in the Project’s development. Highlights Maiden JORC MRE: The Tiros Project boasts 1.7 billion tonnes (bn tonnes) at 3,900 parts per million (“ppm”) Total Rare Earth Oxide (“TREO”), 1,100 ppm Magnet Rare Earth Oxides (“MREO”), and 12% Titanium Dioxide (“TiO2”) in all three resource categories. High Grade Domain: Within the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.